Article
Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome.
Carcinogenesis - 1 Sept 2015
Eng Lawson, Azad Abul Kalam, Qiu Xin, Kong Qin Quinn, Cheng Dangxiao, Ying Nanjiao, Tse Alvina, Kuang Qin, Dodbiba Lorin, Renouf Daniel J, Marsh Sharon, Savas Sevtap, Mackay Helen J, Knox Jennifer J, Darling Gail E, Wong Rebecca K S, Xu Wei, Liu Geoffrey, Faluyi Olusola O
Abstract excerpt
Polymorphisms in the vascular endothelial growth factor (VEGF)/angiogenesis pathway have been implicated previously in cancer risk, prognosis and response to therapy including in esophageal adenocarcinoma. Prior esophageal adenocarcinoma studies focused on using candidate polymorphisms, limiting the discovery of novel polymorphisms. Here, we applied the tagSNP (single nucleotide polymorphism) approach to identify...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
